MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026MZE782 Phase 1 Healthy Volunteer ...

NORCROSS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...

Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 4 of its ...

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare ...

The Senate confirmed two of President Donald Trump’s health nominees Tuesday evening, largely along party lines, in a win for ...

UNICEF has warned that at least 14 million children worldwide are suffering from malnutrition and facing further disruption ...

Scott Dixon (photo) showed a flair for the dramatic Thursday on the IMS road course, turning the quickest time of the test on his final lap in the No. 9 PNC Bank Chip Ganassi Racing Honda.

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based platform for minimal residual disease (MRD) testing detected cancer ...

Trump slams The Atlantic after editor reveals he was included in classified group chat discussing airstrikes: Live - ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but ...